Analysis of 24-h blood pressure profile by Fourier series during lacidipine therapy
- PMID: 7609498
- DOI: 10.1097/00005344-199423005-00026
Analysis of 24-h blood pressure profile by Fourier series during lacidipine therapy
Abstract
In the present study, we examined the circadian profile of blood pressure (BP) in 10 patients with moderate essential hypertension before and after 6 months of lacidipine therapy. Ambulatory BP was measured at 30-min intervals using SpaceLabs 90207. To account for the unequal time intervals between successive readings, BP means and variances were weighted for the time span between successive readings, and weighted linear-regression analysis was applied. The 24-h BP values were carried out using Fourier analysis, comparing the values from the baseline with those after 24 weeks of lacidipine. After 24 weeks BP values showed a significant decreased compared with baseline values (all p < 0.01). The daily BP curves obtained from Fourier analysis with four harmonics showed that the significant circadian rhythm in nine patients was not altered by lacidipine treatment. The night/day differences were statistically significant at 24 weeks vs. 0 week (all p < 0.01). The overall amplitude and acrophase of the BP curve were statistically significant at 24 weeks (all p < 0.01). After 24 weeks of lacidipine therapy, according to the nocturnal BP fall, we found three intermediate dippers, six dippers, and one non-dipper. By use of the two-step Fourier analysis method, which provides a formal and statistical method to evaluate the presence of a significant diurnal BP rhythm and parametrization of the 24-h BP recordings, we showed that lacidipine long-term therapy is effective in lowering BP and preserving the diurnal BP rhythm.
Similar articles
-
[Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Aug;25(8):710-4. Zhonghua Liu Xing Bing Xue Za Zhi. 2004. PMID: 15555399 Chinese.
-
Additive hypotensive effect of a dihydropyridine calcium antagonist to that produced by a thiazide diuretic: a double-blind placebo-controlled crossover trial with ambulatory blood pressure monitoring.J Cardiovasc Pharmacol. 1997 Mar;29(3):412-6. doi: 10.1097/00005344-199703000-00016. J Cardiovasc Pharmacol. 1997. PMID: 9125681 Clinical Trial.
-
Long-acting lacidipine versus short-acting nifedipine in the treatment of asymptomatic acute blood pressure increase.J Cardiovasc Pharmacol. 1999 Mar;33(3):479-84. doi: 10.1097/00005344-199903000-00019. J Cardiovasc Pharmacol. 1999. PMID: 10069685 Clinical Trial.
-
[24-hour perfect BP-lowering therapy using long-acting dihydropyridine calcium channel blockers].Nihon Rinsho. 2014 Aug;72(8):1461-5. Nihon Rinsho. 2014. PMID: 25167753 Review. Japanese.
-
Lacidipine and circadian variation in blood pressure: considerations for therapy.J Cardiovasc Pharmacol. 1991;17 Suppl 4:S20-5; discussion S25-6. J Cardiovasc Pharmacol. 1991. PMID: 1726001 Review.
Cited by
-
A non-invasive method to assess cerebral perfusion pressure in geriatric patients with suspected cerebrovascular disease.PLoS One. 2015 Mar 19;10(3):e0120146. doi: 10.1371/journal.pone.0120146. eCollection 2015. PLoS One. 2015. PMID: 25789855 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical